Doroin, Michelle .
HRN: 00-71-95 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
CEFUROXIME 1.5GM (VIAL)
03/25/2025
03/26/2025
IV
1.5 G
Q8
SP TAHBSO
Waiting Final Action
03/25/2025
CEFUROXIME 500MG (TAB)
03/26/2025
04/02/2025
PO
1 Tab
BID
SP TAHBSO
Waiting Final Action